The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 FIH study of novel oral SERD FWD1802 in patients with ER+/HER2- unresectable locally advanced or metastatic breast cancer with or without ESR1 mutations.
 
Yanchun Meng
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Yehui Shi
No Relationships to Disclose
 
Fei Xu
No Relationships to Disclose
 
Huihui Li
No Relationships to Disclose
 
Yuping Sun
No Relationships to Disclose
 
Xian Wang
No Relationships to Disclose
 
Hai Hu
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Xiujuan Qu
No Relationships to Disclose
 
Min Yan
No Relationships to Disclose
 
Hui Li
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Weimin Xie
No Relationships to Disclose
 
Jing Wu
Employment - Shenzhen Forward Pharmaceuticals
 
Jialin Gu
Employment - Shenzhen Forward Pharmaceuticals
 
Xun Liu
Employment - Shenzhen Forward Pharmaceuticals
 
Huiwen Ge
Employment - Shenzhen Forward Pharmaceuticals
 
Yue Wang
Employment - Shenzhen Forward Pharmaceuticals
 
Chenggang Zhu
Employment - Shenzhen Forward Pharmaceuticals
Leadership - Shenzhen Forward Pharmaceuticals
Stock and Other Ownership Interests - Shenzhen Forward Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Shenzhen Forward Pharmaceuticals